C9orf72 poly(PR) aggregation in nucleus induces ALS/FTD-related neurodegeneration in cynomolgus monkeys

被引:5
|
作者
Xu, Lizhu [1 ]
Wang, Dan [2 ]
Zhao, Lu [1 ,3 ]
Yang, Zhengsheng [1 ,3 ]
Liu, Xu [1 ]
Li, Xinyue [1 ]
Yuan, Tingli [1 ]
Wang, Ye [5 ]
Huang, Tianzhuang [1 ,3 ]
Bian, Ning [1 ]
He, Yuqun [1 ,3 ]
Chen, Xinglong [1 ,3 ]
Tian, Baohong [1 ,3 ]
Liu, Zexian [5 ]
Luo, Fucheng [1 ,3 ]
Si, Wei [1 ,3 ]
Gao, Guangping [2 ]
Ji, Weizhi [1 ,3 ]
Niu, Yuyu [1 ,3 ,4 ]
Wei, Jingkuan [1 ]
机构
[1] Kunming Univ Sci & Technol, Inst Primate Translat Med, State Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China
[2] Univ Massachusetts Chan Med Sch, Horae Gene Therapy Ctr, Worcester, MA 01605 USA
[3] Yunnan Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China
[5] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
基金
中国国家自然科学基金;
关键词
ALS; C9orf72; Poly(PR); CHIT1; cynomolgus monkeys; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; RETT-SYNDROME; MOTOR-NEURONS; EXPANSION; PROTEINS; GENES; ALS; CONTRIBUTE; FEATURES;
D O I
10.1016/j.nbd.2023.106197
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Poly(PR) is a dipeptide repeat protein comprising proline and arginine residues. It is one of the translational product of expanded G4C2 repeats in the C9orf72 gene, and its accumulation is contributing to the neuropathogenesis of C9orf72-associated amyotrophic lateral sclerosis and/or frontotemporal dementia (C9-ALS/ FTD). In this study, we demonstrate that poly(PR) protein alone is sufficient to induce neurodegeneration related to ALS/FTD in cynomolgus monkeys. By delivering poly(PR) via AAV, we observed that the PR proteins were located within the nucleus of infected cells. The expression of (PR)50 protein, consisting of 50 PR repeats, led to increased loss of cortical neurons, cytoplasmic lipofuscin, and gliosis in the brain, as well as demyelination and loss of ChAT positive neurons in the spinal cord of monkeys. While, these pathologies were not observed in monkeys expressing (PR)5, a protein comprising only 5 PR repeats. Furthermore, the (PR)50-expressing monkeys exhibited progressive motor deficits, cognitive impairment, muscle atrophy, and abnormal electromyography (EMG) potentials, which closely resemble clinical symptoms seen in C9-ALS/FTD patients. By longitudinally tracking these monkeys, we found that changes in cystatin C and chitinase-1 (CHIT1) levels in the cerebrospinal fluid (CSF) corresponded to the phenotypic progression of (PR)50-induced disease. Proteomic analysis revealed that the major clusters of dysregulated proteins were nuclear-localized, and downregulation of the MECP2 protein was implicated in the toxic process of poly(PR). This research indicates that poly(PR) expression alone induces neurodegeneration and core phenotypes associated with C9-ALS/FTD in monkeys, which may provide insights into the mechanisms of disease pathogenesis.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] RAN translation in C9orf72 ALS/FTD and other repeat opportunities
    Ranum, L.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S129 - S129
  • [32] Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Jamie C Fong
    Anna M Karydas
    Jill S Goldman
    Alzheimer's Research & Therapy, 4
  • [33] Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD
    Ming-Yuan Su
    Simon A. Fromm
    Roberto Zoncu
    James H. Hurley
    Nature, 2020, 585 : 251 - 255
  • [34] Cognitive Endophenotype Associated with the C9ORF72 GGGGCC Expansion in FTD/ALS
    Pedraza, Otto
    Boeve, Bradley
    DeJesus-Hernandez, Mariely
    Rush, Beth
    Lucas, John
    Fields, Julie
    Machulda, Mary
    Graff-Radford, Neill
    Knopman, David
    Josephs, Keith
    Rutherford, Nicola
    Baker, Matthew
    Ferman, Tanis
    Smith, Glenn
    Ivnik, Robert
    Wszolek, Zbigniew
    Boylan, Kevin
    Petersen, Ronald
    Rademakers, Rosa
    NEUROLOGY, 2012, 78
  • [35] Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD
    Su, Ming-Yuan
    Fromm, Simon A.
    Zoncu, Roberto
    Hurley, James H.
    NATURE, 2020, 585 (7824) : 251 - +
  • [36] C9orf72 ALS/FTD: Challenges and New Opportunities in Translational Research
    Ranum, Laura
    Romano, Lisa E. L.
    Zu, Tao
    Nguyen, Lien
    Guo, Shu
    Davidson, Beverly L.
    Ranum, Laura P. W.
    ANNALS OF NEUROLOGY, 2024, 96 : S299 - S300
  • [37] C9orf72 repeat expansions are restricted to the ALS-FTD spectrum
    Ticozzi, Nicola
    Tiloca, Cinzia
    Calini, Daniela
    Gagliardi, Stella
    Altieri, Alessandra
    Colombrita, Claudia
    Cereda, Cristina
    Ratti, Antonia
    Pezzoli, Gianni
    Borroni, Barbara
    Goldwurm, Stefano
    Padovani, Alessandro
    Silani, Vincenzo
    NEUROBIOLOGY OF AGING, 2014, 35 (04) : 936.e13 - 936.e17
  • [38] Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
    Mayl, Keith
    Shaw, Christopher E.
    Lee, Youn-Bok
    BIOMEDICINES, 2021, 9 (06)
  • [39] An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
    Edbauer, Dieter
    Haass, Christian
    CURRENT OPINION IN NEUROBIOLOGY, 2016, 36 : 99 - 106
  • [40] Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases
    Riboldi, Giulietta
    Zanetta, Chiara
    Ranieri, Michela
    Nizzardo, Monica
    Simone, Chiara
    Magri, Francesca
    Bresolin, Nereo
    Comi, Giacomo P.
    Corti, Stefania
    MOLECULAR NEUROBIOLOGY, 2014, 50 (03) : 721 - 732